Q2 2022 VolitionRX Ltd Earnings Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to VolitionRx Limited's second-quarter '22 earnings conference call. (Operator Instructions) This conference is being recorded today, August 11, 2022.
I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.
Thank you, and welcome, everyone, to today's earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the second quarter of 2022, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session.
Also on our call today Mr. Cameron Reynolds, President and CEO; Dr. Tom Butera, Chief Executive Officer of our Volition Veterinary subsidiary; and Mr. Terig Hughes, Chief Financial Officer.
Before we begin, I'd like to remind everyone that some of the information discussed on this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |